Dementia expert says evidence behind Biogen Alzheimer's drug 'wasn’t sufficient' for FDA approval

cnbc2021-06-08

Dementia expert Dr. Jason Karlawish told CNBC he's skeptical of theFood and Drug Administration's approvalofBiogen's Alzheimer's disease drug, Aduhelm, saying "the evidence to approve the drug wasn't ...

网页链接
免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

发表看法
12